Диссертация (1174314), страница 28
Текст из файла (страница 28)
et al. MiRNA-directed regulation of VEGF and otherangiogenic factors under hypoxia // PLoS ONE. – 2006. – Vol.1. – e116.171. Huang H.Y. Medical treatment of endometriosis // Chang Gung Med J. –2008. – Vol.31. – P.431-440.165172. Hughes E., Brown J., Collins J.J. et al. Ovulation suppression forendometriosis // Cochrane Database Syst Rev.
– 2007. – Vol.3. – CD000155.173. Huhtien K., Suvitie P., Hiissa J. et al. Serum HE4 concentrationdifferentiates malignant ovarian endometriotic cysts // Br J Cancer. – 2009. – Vol.100. –№8. – P.1315-1319.174. Izawa M., Harada T., Taniguchi F. et al. An epigenetic disorder may causeaberrant expression of aromatase gene in endometriotic stromal cells // Fertil Steril. –2008. – №.89. – P.1390-1396.175. Ishihara H., Kitawaki J., Kado N. et al. Gonadotropin-releasing hormoneagonist and danasol normalize aromatase cytochrome P450 expression in eutopicendometrium from women with endometriosis, adenomyosis, or leiomyomas // FertilSteril. – 2003. – №.1. – P.1390-1396.176.
Jee B.C., Lee J.Y., Suh C.S. et al. Impact of GnRH agonist treatment onrecurrence of ovarian endometriomas after conservative laparoscopic surgery // FertilSteril. – 2009. – Vol.91. – №1. – P.40-45.177. Jee B.C., Suh C.S., Kim S.H., Moon S.Y. Serum soluble CD163 andinterleukin-6 levels in women with ovarian endometriomas // Gynecol Obstet Invest. –2008. – №.66. – P.47-52.178.
Jia S.Z., Yang Y., Lang J. et al. Plasma miR-17-5p, miR-20a and miR-22 aredown-regulated in women with endometriosis // Hum Reprod. – 2013. – Vol.28. – №2. –P.322-330.179. Jiang Q.Y., Wu R.J. Growth mechanisms of endometriotic cells in iplantedplaces: a review // Gynecol Endocrinol. – 2012. – Vol.28.
– №7. – P.562-567.180. Jiang Y., Tang J.Y., Wu Y., Zhao T.F. Vascolar endothelial growth factor genepolymorphisms and the risk of endometriosis: a systematic review // Zhonghua Fu ChanKe Za Zhi. – 2012. – Vol.47. – №3. – P.179-184.181. Johnson M.C., Torres M., Alves A. et al. Augmented cell survival in eutopicendometrium from women with endometriosis: expression of c-myc, TGF-beta1 andbax genes // Reprod Biol Endocrinol. – 2005. – Vol.8. – №3. – P.45.166182.
Kalu E., Sumar N., Giannopoulos T. et al. Cytokine profiles in serum andperitoneal fluid from infertile women with and without endometriosis // J ObstetGynaecol Res. – 2007. – Vol.33. – №4. – P.490-495.183. Kang S., Wang Y. Zhang J.H. et al. Single nucleotide polymorphism in thematrix metalloproteinases promoter is associated with susceptibility to endometriosisand adenomyosis // Zhonghua Fu Chan Ke Za Zhi. – 2005.
– Vol.40. – №9. – P.601-604.184. Kang Y.J., Li Y., Sun X. Antiapoptotic effect and inhibition ofischemia/reperfusion-induced myocardial injury in metallothionein-overexpressingtransgenic mice // Am J Pathol. – 2003. – №163. – P.1579-1586.185. Karlsen M.A., Sandhu N., Hogdall C. et al. Evaluation of HE4, CA125, riskof ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) asdiagnostic tools of epithelial ovarian cancer in patients with a pelvic mass // GynecolOncol. – 2012. – Vol.127. – №2.
– P.379-383.186. Katayama H., Katayama T., Uematsu K. et al. Effect of dienogestadministration on angiogenesis and hemodynamics in a rat endometrial autograft model// Hum Reprod. – 2010. – Vol.25. – №11. – P.2851-2858.187. Khoufache K., Bazin S., Girard K. et al. Macrophage Migration InhibitoryFactor Antagonist blocks the development of endometriosis in vivo // PLoS One. –2012. – Vol.7.
– №5. – e37264.188. Kim J.J., Taylor H.S., Lu Z. et al. Altered expression of HOXA10 inendometiosis: potential role in decidualization // Mol Hum Reprod. – 2007. – №.13. –P.323-332.189. Kim J.Y., Jee B.C., Suh C.S., Kim S.H. Preoperative serum anti-mullerianhormone level in women with ovarian endometrioma and mature cystic teratoma //Yonsei Med J.
– 2013. – Vol.54. – №4. – P.921-926.190. Kipping C., Duijkers I., Faustmann T.A. et al. Pharmacodynamic study offour oral dosages of dienogest // Fertil Steril. – 2010. –Vol.94. – S181.191. Kitawaki J., Ishihara H., Koshiba H. et al. Usefulness and liits of CA-125 indiagnosis of endometriosis without associated ovarian endometriomas // Hum Reprod. –2005. – Vol.20. – №7. – P.1999-2003.167192. Kobayashi H., Sumimoto K., Kitanaka T. et al. Ovarian endometrioma – riskfactors of ovarian cancer development // Eur J Obstet Gynecol Reprod Biol. – 2008.
–Vol.138. – №2. – P.187-193.193. Kocbek V., Grandi G., Blank F. et al. TNFα-induced IKKβ complexactivation influences epithelial, but not stromal cell survival in endometriosis // MolHum Reprod. – 2016. – Vol.22. – №11. – P.768-777.194. Koukoura O., Sifakis S., Spandidos D.A. DNA methylation in endometriosis(Review) // Mol Med Rep. – 2016. – Vol.13. – №4. – P.2939-2948.195. Kumar S., Bandyopadhyay U. Free heme toxicity and its detoxificationsystem in human // Toxicol Lett. – 2005.
–№157. – P.175-188.196. La Marca A., Siqhinolfi G., Radi D. et al. Anti-Mullerian hormone (AMH)as a predictive marker in assisted reproductive technolog (ART) // Hum Reprod Update.– 2010. – Vol.16. – №2. – P.113-130.197. Lee B., Du H., Taylor H.S. Experimental murine endometriosis inducesDNA methylation and altered gene expression in eutopic endometrium // Biol Reprod. –2009.
– №.80. – P.79-85.198. Lee J.H., Song J.Y. Effectiveness of Dienogest for Treatment of RecurrentEndometriosis: Multicenter Data // Reprod Sci. – 2018. - Jan 1:1933719118779733.199. Lee S., Kim M., Seong S. et al. Recurrence of Ovarian Endometrioma inAdolescents after Conservative, Laparoscopic Cyst Enucleation // J Pediatr AdolescGynecol. – 2017. - №30 (2). – Р.228-233.200. Litta P., D’Agostino G., Conte L. et al. Anti-Mullerian hormone trend afterlaparoscopic surgery in women with ovarian endometrioma // Gynecol Endocrinol. –2013.
– Vol.29. – №5. – P.452-454.201. Londero A.P., Calcagno A., Grassi T. et al. Survivin, MMP-2, MT1-MMP,and TIMP-2: their impact on survival, implantation, and proliferation of endometriotictissues // Virchows Arch. – 2012. – Vol.461. – №5. – P.589-599.202. Lousse J.C., Defrere S., Van Langendonckt A. et al. Iron storage issignificantly increased in peritoneal macrophages of endometriosis patients ans168correlates with iron overload in peritoneal fluid // Fertil Steril. – 2009.
–№91. – P.16681675.203. Lousse J.C., Van Langendonckt A., Defrere S. et al. Peritoneal endometriosisis an inflammatory disease // Front Biosci (Elite Ed.). – 2012. –№4. – P.23-40.204. Lowe K.A., Shah C., Wallace E. Effects of personal characteristics on serumCA125, mesothelin, and HE4 levels in healhy postmenopausal women at high-risk forovarian cancer // Cancer Epidemiol Biomarkers Prev. – 2008.
– Vol.17. – P.2480-2487.205. Maia H,Jr, Haddad C., Casoy J. Correlation between aromatase expression inthe eutopic endometrium of symptomatic patients and the presence of endometriosis //Int J Womens Health. – 2012. – №4. – P.61-65.206. Martinez S., Garrido N., Coperias J.L. et al. Serum interleukin-6 levels areelevated in women with minimal-mild endometriosis // Hum Reprod. – 2007. – №.22. –P.836-842.207. Mattews J., Gustafsson J.A. Estrogen signaling: a subtle balance betweenER alpha and beta // Mol.
Interv. – 2003. – Vol.3. – №5. – P.281-292.208. May K.E., Conduit-Hulbert S.A., J Villar et al. Peripheral biomarkers ofendometriosis: a systematic review // Hum Reprod Update. – 2010. – Vol.16. – №6. –P.651-674.209. McLaren J. Vascular endothelial growth factor and endometrioticangiogenesis // Hum Reprod Update. – 2000. – Vol.6. – №1. – P.45-55.210.
Melin A., Sparen P., Persson I. et al. Endometriosis and the risk of cancerwith special emphasis on ovarian cancer // Hum Reprod. – 2006. – Vol.21. –P.12371242.211. Molina R., Escudero J.M., Auqe J.M. et al. HE4 a novel tumor marker forovarian cancer: comparison with CA125 and ROMA algorithm in patients withgynaecological diseases // Tumor Biol. – 2011.
– Vol.32. – №6. – P.1087-1095.212. Montagna P., Capellino S., Villaggio B. et al. Peritoneal fluid macrophagesin endometriosis: correlation between the expression of estrogen receptors andinflammation // Fertil Steril. – 2008. – Vol.90. – №1. – P.156-164.169213. Moor R., Brown A., Miller M. et al. The use of multiple novel tumorbiomarkers for the detection of ovarian carcinoma in patients with a pelvic mass //Gynecol Oncol. – 2008. – Vol.108. – P.402-408.214.
Morin M., Bellehumeur C., Therriault M.J. et al. Elevated levels ofmacrophage migration inhibitory factor in the peripheral blood of women withendometriosis // Fertil Steril. – 2005. – Vol.83. – P.865-872.215. Mote P.A., Graham J.D., Clarke C.D. Progesterone receptor isoforms innormal and malignant breast // Ernst Shering Found Symp Proc.
– 2007. – P.77-107.216. Mote P.A., Johnston J.F., Manninen T. et al. Detection of progesteronereceptor forms A and B by immunohistochemical analysis // J Clin Pathol. – №54. –P.624-630.217. Mulac-Jericevic B., Conneely O.M. Reproductive tissue selective actions ofprogesterone receptors // Reproduction. – 2004. – Vol.128. – №2. – P.139-146.218. Munksqaard P.S., Blaakaer J. The association between endometriosis andovarian cancer: a rewiew of histological, genetic and molecular alterations // GynecolOncol. – 2012. – Vol.124. – №1. – P.164-169.219. Mylonas I., Makovitzky J., Friese K., Jeschke U.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
